Related content

Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women

By Oviedo Pilar   Hermenegildo Carlos   Sobrino Agua   Tarin Juan   Cano Antonio  

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 354-357

Informa Healthcare

Access to resources Recommend Favorite

Flutamide–metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

By Ibáñez Lourdes  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1725-1727

Oxford University Press

Access to resources Recommend Favorite

Discontinuous low-dose flutamide–metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-α and the neutrophil/lymphocyte ratio

By Ibáñez Lourdes   Valls Carme   de Zegher Francis  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 451-456

Oxford University Press

Access to resources Recommend Favorite

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

By Reinboldt Stephan   Wenzel Folker   Rauch Bernhard   Hohlfeld Thomas   Grandoch Maria   Fischer Jens   Weber Artur-Aron  

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 441-444

Informa Healthcare

Access to resources Recommend Favorite

Soluble CD40 Ligand Levels in Patients with Hypertension

By Sonmez Alper   Dogru T.   Yilmaz M.   Ocal R.   Ozgurtas T.   Kilic S.   Eyileten T.   Tasci I.   Erbil K.   Kocar I.  

Clinical and Experimental Hypertension, Vol. 27, Iss. 8, 2005-11 ,pp. : 629-634

Informa Healthcare

Access to resources Recommend Favorite